Related Topics News -

     
 Title only   |   Print    Next page > 
     
內地十部門印發醫藥工業「十五五」規劃 2030年營收目標不少於3.5萬億人幣

2026-09-18T  
內地2026年國家醫保藥品目錄料11月發佈

2026-09-09T  
《大行》高盛:國藥控股第二季業績符預期 降目標價至18.46元

2026-08-26T  
《大行》里昂降國藥目標價至21.1元 重申「跑贏大市」評級

2026-08-26T  
國藥控股跌3.6% 花旗下調目標價至20.4元

2026-08-25T  
《大行》大和降國藥目標價至17元 上半年業績略遜預期

2026-08-25T  
國藥控股附屬國藥一致半年賺6.06億人民幣 倒退9%

2026-08-17T  
內地新一批國家藥品集採納入65個品種

2026-08-03T  
特朗普:2028年8月起對進口仿製藥徵收100%關稅

2026-07-22T  
中國上半年創新藥對外授權交易額逾1,000億美元 再創新高

2026-07-20T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.